As part of its longstanding commitment to Africa, Johnson & Johnson today announced the launch of the Africa Innovation Challenge, an initiative to support Africa’s vibrant and growing innovation ecosystem and to help develop important and locally sustainable consumer health solutions. The challenge is the latest initiative in the company’s comprehensive approach to advancing health and innovation worldwide. The Johnson & Johnson Family of Companies’ presence in Africa dates back more than 80 years and includes business operations, public health programs and corporate citizenship.
“Through the Africa Innovation Challenge, we have the opportunity to support the continent’s top entrepreneurs through mentorship and other resources, and by working together with local talent, to bring forward new solutions to local health care challenges,” said Paul Stoffels, M.D., Executive Vice President and Chief Scientific Officer, Johnson & Johnson.
To view the multimedia release go to:
http://www.multivu.com/players/English/7967451-jnj-africa-innovation-challenge/
Online summer school enrollment is now open to K-12 students everywhere; offered by International Connections Academy (iNaCA), the U.S.-based accredited virtual private school serving students worldwide. Families are invited to attend an online information session to learn more about the benefits of online summer school.
iNaCA summer school students stay engaged academically while enjoying the freedom of summer. With more than 100 online courses - including NCAA eligible courses - flexible start dates, and enrichment opportunities, iNaCA's online summer school is an option for students interested in earning necessary credit, exploring fresh interests, and building new skills. Students also can use the innovative online summer program as a pathway to early graduation.
To view the multimedia release go to:
https://www.multivu.com/players/English/8007151-international-connections-academy-online-summer-school/
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
Petmate, the worldwide leader of solutions and excellence in the pet industry providing trusted, quality products to enhance the lives of pets and their families, is launching a revolutionary new anxiety relief system for dogs. The Calmz Anxiety Relief System is now available at pet specialty and online retailers nationwide in time for the summer season of fireworks, thunderstorms and travel. For more information, visit calmz.com.
Nearly 75 million dogs owned by American families suffer from anxiety at some point in their lives, particularly as a result of thunderstorms, fireworks, encounters with strangers, travel and loud noises. About 24 million of them chronically suffer from these debilitating issues. Now Petmate introduces a new way to help relieve that anxiety.
To view the multimedia release go to:
https://www.multivu.com/players/English/8115451-petmate-calmz-anxiety-relief-system/
Hennessy, the world’s best-selling Cognac, is proud to announce urban artist JonOne as the designer of the 2017 Hennessy Very Special Limited Edition bottle. The custom-designed bottle, launching across the U.S. in July 2017, will be sold in almost 50 countries worldwide. The Limited Edition release by JonOne, which features a colorful, vibrant design, is the seventh in an ongoing series of collaborations between Hennessy V.S and several internationally renowned artists.
Hennessy sensed a kindred spirit in JonOne. Constantly on the move between his home in Paris, his native Harlem and cutting-edge art scenes all over the world, the street artist-turned-art-world phenomenon has always remained true to himself, pushing boundaries and defying definition. For JonOne, art is a vector for pure emotion. What drives him is being “in the flow” and “sharing dreams.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8120351-hennessy-jonone-very-special-limited-edition-bottle/
Melbourne-born Quay Australia, a leading eyewear company, announces a high-profile sunglass collaboration with pop culture phenomenon and entrepreneur, Kylie Jenner.
The QUAYXKYLIE capsule collection—comprised of 4 styles and 11 skus—will be available beginning July 11th at www.QuayAustralia.com and retailers worldwide for $75-$80 USD each.
“We’ve found the perfect collaborator in Kylie. Her social influence is unparalleled and she is known for her dynamic style and edge that her followers want to emulate,” says Quay Australia founder, Linda Hammond.
To view the multimedia release go to:
https://www.multivu.com/players/English/8127151-quay-australia-kylie-jenner-sunglass-collection-quayxkylie/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Cocktail fans are likely familiar with ANGOSTURA aromatic bitters® and the enhancing effect bitters can have on alcoholic beverages, but what they might not know is that the story of THE HOUSE OF ANGOSTURA® and ANGOSTURA® aromatic bitters spans beyond craft cocktails. THE HOUSE OF ANGOSTURA wants consumers to take inspiration from the brand’s rich history to make ANGOSTURA aromatic bitters an everyday staple. From culinary uses to signature cocktails, such as the Queen’s Park Swizzle, THE HOUSE OF ANGOSTURA is making a push to ensure ANGOSTURA aromatic bitters secure a permanent spot not only in consumers’ bar carts but also in their pantries.
“Visitors will find ANGOSTURA aromatic bitters alongside salt and pepper in any establishment on the islands of Trinidad and Tobago. We sprinkle a few drops on everything from pizza to soup, ensuring a kick of bold flavor in everything we consume,” said THE HOUSE OF ANGOSTURA CEO Genevieve Jodhan. “I am delighted that people worldwide are already integrating ANGOSTURA bitters into their favorite cocktail recipes, but my hope is that consumers will continue to discover that bitters’ versatile flavor can enhance everything from easy week-night meals to extravagant desserts.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8163051-the-house-of-angostura-bitters-culinary-creations-cocktails/
The sound of mazurkas and polonaises is known worldwide; Fryderyk Chopin was a musical genius who continues to inspire artists and mesmerize music lovers. While he lived 200 years ago, visitors can now experience his life and works on a tour in Warsaw. Chopin spent over half his life in Poland’s capital, and his music lives on in Warsaw’s concert halls, parks and city streets.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8172551-warsaw-city-hall-chopin-tour-apps-poland/
In honor of World Pancreatic Cancer Day on Nov. 16, people around the world will come together to Demand Better in the fight against the world’s toughest cancer, starting with earlier diagnosis. The annual one-day campaign is an initiative of the World Pancreatic Cancer Coalition, which is comprised of more than 60 organizations from 27 countries on six continents.
Every day, more than 1,000 people worldwide will be diagnosed with pancreatic cancer. Of that, an estimated 985 will die from the disease. Additionally, pancreatic cancer has the lowest survival rate among all major cancers, and in nearly every country, it is the only major cancer with a single-digit five-year survival rate (2-9 percent). These stunning figures are not merely statistics, they represent family members, friends and colleagues on every corner of the globe.
“This year, we are turning World Pancreatic Cancer Day from a day of awareness to a day of action,” said Julie Fleshman, JD, MBA, World Pancreatic Cancer Coalition chair. “As we expand our global movement to end pancreatic cancer, we are demanding better for pancreatic cancer patients now and in the future.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8201651-world-pancreatic-cancer-day-demand-better/
Based on the groundbreaking HBO® series, GAME OF THRONES: The Touring Exhibition will give fans the experience of a lifetime with an up-close and personal look into the world of Westeros and Essos. In collaboration with HBO Global Licensing, global events provider GES designed and built the show’s largest public display to date. The exhibition beautifully showcases the sumptuous costumes, authentic props, and majestic settings from all seven seasons of the worldwide hit series GAME OF THRONES in an interactive, immersive experience which leads visitors through several dynamically themed exhibition areas. Sold Out and Encore are partnering with GES to present the exhibition in Barcelona.
GAME OF THRONES actors Tom Wlaschiha, who played Faceless Man Jaqen H'ghar, and Ian Beattie, who played Kingsguard Knight Meryn Trant, were on hand to celebrate the grand opening.
“It is an incredible honor to join my co-star at the opening of GAME OF THRONES: The Touring Exhibition in Barcelona. It has been a trip down memory lane to see all of the props and costumes again. I highly recommend it to fans and newcomers alike,” said Ian Beattie.
To view the multimedia release go to:
https://www.multivu.com/players/English/8194651-game-of-thrones-touring-exhibition-barcelona/
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7.
With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process.
To view the multimedia release go to:
https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
